2019
DOI: 10.1007/s12026-019-09088-6
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of immunomodulatory properties of exosomes derived from bone marrow mesenchymal stem cells and dental pulp stem cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
84
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(85 citation statements)
references
References 44 publications
0
84
0
1
Order By: Relevance
“…An in vitro study revealed that DPSCs-derived exosomes (DPSCs-Exos) inhibited the differentiation of CD4 + T cells into T helper 17 cells (Th17) and reduced the secretion of the pro-inflammatory factors IL-17 and TNF-α. [38] DPSCs-Exos effectively promoted the polarization of CD4 + T cells into Treg cells and increased the release of the anti-inflammatory factors IL-10 and TGF-β. [38] These capabilities of DPSCs-Exos were stronger than BMSCs-Exos, except in the inhibition of the proliferation of the CD4 + T cells, which suggests DPSCs-Exos as a new therapeutic tool for the treatment of immunological diseases.…”
Section: Immunomodulatory Effectsmentioning
confidence: 98%
See 1 more Smart Citation
“…An in vitro study revealed that DPSCs-derived exosomes (DPSCs-Exos) inhibited the differentiation of CD4 + T cells into T helper 17 cells (Th17) and reduced the secretion of the pro-inflammatory factors IL-17 and TNF-α. [38] DPSCs-Exos effectively promoted the polarization of CD4 + T cells into Treg cells and increased the release of the anti-inflammatory factors IL-10 and TGF-β. [38] These capabilities of DPSCs-Exos were stronger than BMSCs-Exos, except in the inhibition of the proliferation of the CD4 + T cells, which suggests DPSCs-Exos as a new therapeutic tool for the treatment of immunological diseases.…”
Section: Immunomodulatory Effectsmentioning
confidence: 98%
“…[38] DPSCs-Exos effectively promoted the polarization of CD4 + T cells into Treg cells and increased the release of the anti-inflammatory factors IL-10 and TGF-β. [38] These capabilities of DPSCs-Exos were stronger than BMSCs-Exos, except in the inhibition of the proliferation of the CD4 + T cells, which suggests DPSCs-Exos as a new therapeutic tool for the treatment of immunological diseases. MiR-100-5p was enriched in exosomes derived from SHEDs and suppressed the temporomandibular joint (TMJ) chondrocyte expression of interleukin-6 (IL-6), IL-8, matrix metalloproteinase 1 (MMP1), MMP3, MMP9, MMP13, disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) [39].…”
Section: Immunomodulatory Effectsmentioning
confidence: 98%
“…EVs regulate dendritic cell functions with impairment of antigen uptake by immature cells and reductions in cell maturation and activation [46]. Although there are differences depending on the parent cells, MSC EVs may inhibit the proliferation of CD4 + and CD8 + T cells and the promotion of apoptosis in CD4 + T cells [47,48]. EVs may also promote the conversion of T helper type 1 (Th1) into T helper type 2 (Th2) cells whereas differentiation into Th17 cells was decreased [44].…”
Section: Immune Regulation and Rheumatoid Arthritismentioning
confidence: 99%
“…EVs may also promote the conversion of T helper type 1 (Th1) into T helper type 2 (Th2) cells whereas differentiation into Th17 cells was decreased [44]. In addition, EVs polarize activated CD4 + T cells to CD4 + CD25 + FOXP3 + regulatory T cells (Tregs) which requires activation of T cells by antigen presenting cells [47,49,50]. As MSC EVs polarize immune cells toward an immunosuppressive phenotype only in the presence of an activated immune system [50], homeostatic immune activity would not be affected by EVs treatment thus avoiding the increased risk of infection or cancer observed with immunosuppressive drugs [51].…”
Section: Immune Regulation and Rheumatoid Arthritismentioning
confidence: 99%
“…This characteristic of DPSC-derived exosomes can play a significant role in cell-free therapy for various autoimmune diseases. [ 12 ]…”
Section: T Herapeutic a Pplications Of mentioning
confidence: 99%